Home › Type 2 Diabetes › New Mexico
Type 2 Diabetes clinical trials in New Mexico
11 studies for Type 2 Diabetes are looking for participants at sites in New Mexico.
Cities in New Mexico
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Albuquerque Clinical Trials, Inc., Albuquerque
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07595549A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Albuquerque Clinical Trials, Inc., Albuquerque
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07282600A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Albuquerque Clinical Trials, Albuquerque
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07754461EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- New Mexico Clinical Research and Osteoporosis Center, Inc., Albuquerque
- IMA Clinical Research Albuquerque, Albuquerque
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07064473A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
- Albuquerque Clinical Trials Inc, Albuquerque
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 15, 2026 · NCT07340320A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Albuquerque
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07662213Ketogenic Diet and Diabetes Demonstration Project
- University of New Mexico, Albuquerque
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT06115265A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Research Site, Albuquerque
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT07662135A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Albuquerque
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 31, 2026 · NCT07662109A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- University of New Mexico Hospital, Albuquerque
RecruitingPhase 3
Ages 10 to 17 · All sexes · Updated Aug 7, 2026 · NCT06739122DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
- Colorado Navajo Nation, Shiprock
RecruitingObservational study
Ages 8 to 15 · All sexes · Updated May 7, 2026 · NCT06525259From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.